许旺样细胞再细胞化脱细胞神经同种异体移植物修复神经缺损的临床前试验
一年随访显示两组功能恢复与神经再生均改善,组织学上再细胞化移植物组神经纤维排列较差但再髓鞘化活跃。
要点
- 许旺样细胞再细胞化脱细胞神经同种异体移植物可成功修复30 mm神经缺损。
- 再细胞化移植物与自体神经移植在功能和神经生理恢复上相似。
- 组织学显示再细胞化移植物神经纤维排列较差但再髓鞘化活跃。
核心结论
- 许旺样细胞再细胞化脱细胞神经同种异体移植物是修复神经缺损的成功治疗方法。
- 两种移植组均与对侧未治疗神经相比满意地实现了运动恢复和神经再生。
研究设计与样本
- 制作30 mm腓神经缺损模型,评估包括组织形态学分析、一年随访功能肢体恢复(支撑和步态)、神经生理测试和组织形态计量分析,均与对侧后肢对照比较。
主要发现
- 神经同种异体移植物成功脱细胞,超过70%的间充质干细胞预分化为许旺样细胞。
- 两个治疗组功能评估随时间类似改善(p<0.05)。
- 十二个月时两组神经生理结果(潜伏期、波幅和传导速度)均改善。
- 十二个月时与对照相比,两组组织学显示神经纤维排列较无序(p<0.05)且再髓鞘化过程活跃(p<0.05)。
临床怎么用
- 该再细胞化脱细胞神经同种异体移植物方法可能适用于周围神经损伤的临床治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Acellular nerve allografts (ANA) recellularized with mesenchymal stem cells (MSC) or Schwann cells (SC) are, at present, a therapeutic option for peripheral nerve injuries (PNI). This study aimed to evaluate the regenerative and functional capacity of a recellularized allograft (RA) compared with autograft nerve reconstruction in PNI. METHODS: Fourteen ovines were randomly included in two groups (n=7). A peroneal nerve gap 30 mm in length was excised, and nerve repair was performed by the transplantation of either an autograft or a recellularized allograft with SC-like cells. Evaluations included a histomorphological analysis of the ANA, MSC pre differentiated into SC-like cells, at one year follow-up functional limb recovery (support and gait), and nerve regeneration using neurophysiological tests and histomorphometric analysis. All evaluations were compared with the contralateral hindlimb as the control. RESULTS: The nerve allograft was successfully decellularized and more than 70% of MSC were pre differentiated into SC-like cells. Functional assessment in both treated groups improved similarly over time (p <0.05). Neurophysiological results (latency, amplitude, and conduction velocity) also improved in both treated groups at twelve months. Histological results demonstrated a less organized arrangement of nerve fibers (p <0.05) with an active remyelination process (p <0.05) in both treated groups compared with controls at twelve months. CONCLUSIONS: ANA recellularized with SC-like cells proved to be a successful treatment for nerve gaps. Motor recovery and nerve regeneration were satisfactorily achieved in both graft groups compared with their contralateral nontreated nerves. This approach could be useful for the clinical therapy of PNI.
引用
- Tamez-Mata Y, Pedroza-Montoya FE, Martínez-Rodríguez HG, et al. Nerve gaps repaired with acellular nerve allografts recellularized with Schwann-like cells: Preclinical trial. J Plast Reconstr Aesthet Surg. 2021. PMID: 34257032. doi:10.1016/j.bjps.2021.05.066
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。